{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T02:54:07Z","timestamp":1782269647305,"version":"3.54.5"},"reference-count":13,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jhep.2023.09.022","type":"journal-article","created":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T05:40:15Z","timestamp":1696916415000},"page":"1349-1351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Macrophages make a difference in cholestatic liver diseases \u2013 but how?"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4247-076X","authenticated-orcid":false,"given":"Christy E.","family":"Trussoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3266-0831","authenticated-orcid":false,"given":"Nicholas F.","family":"LaRusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2023.09.022_bib1","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1056\/NEJMra1909094","article-title":"Reframing immune-mediated inflammatory diseases through signature cytokine hubs","volume":"385","author":"Schett","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2023.09.022_bib2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00281-022-00909-9","article-title":"Cellular senescence in the cholangiopathies: a driver of immunopathology and a novel therapeutic target","volume":"44","author":"Trussoni","year":"2022","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jhep.2023.09.022_bib3","article-title":"Osteopontin characterizes bile duct associated macrophages and correlates with liver fibrosis severity in primary sclerosing cholangitis","author":"De Muynck","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.09.022_bib4","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/HEP.0000000000000270","article-title":"Mapping the hepatic immune landscape identifies monocytic macrophages as key drivers of steatohepatitis and cholangiopathy progression","volume":"78","author":"Guillot","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.09.022_bib5","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jhep.2018.05.018","article-title":"Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice","volume":"69","author":"Guicciardi","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.09.022_bib6","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.jhep.2023.08.016","article-title":"A+T rich interaction domain protein 3a (Arid3a) impairs Mertk-mediated efferocytosis in cholestasis","volume":"79","author":"Chen","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2023.09.022_bib7","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1038\/s41467-023-37213-5","article-title":"A regulatory variant at 19p13.3 is associated with primary biliary cholangitis risk and ARID3A expression","volume":"14","author":"Li","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2023.09.022_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s41401-023-01134-2","article-title":"ARID3a from the ARID family: structure, role in autoimmune diseases and drug discovery","author":"Guo","year":"2023","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"10.1016\/j.jhep.2023.09.022_bib9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/imr.13267","article-title":"TAM receptors in phagocytosis: beyond the mere internalization of particles","volume":"319","author":"Burstyn-Cohen","year":"2023","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jhep.2023.09.022_bib10","first-page":"220","article-title":"Trained immunity of alveolar macrophages enhances injury resolution via KLF4-MERTK-mediated efferocytosis","author":"Chakraborty","year":"2023","journal-title":"J\u00a0Exp Med"},{"issue":"4","key":"10.1016\/j.jhep.2023.09.022_bib11","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s12013-023-01173-w","article-title":"Macrophages serve as bidirectional regulators and potential therapeutic targets for liver fibrosis","volume":"81","author":"Liang","year":"2023","journal-title":"Cell Biochem Biophys"},{"key":"10.1016\/j.jhep.2023.09.022_bib12","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","article-title":"Macrophages as tools and targets in cancer therapy","volume":"21","author":"Mantovani","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jhep.2023.09.022_bib13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/imm.13300","article-title":"Macrophage reprogramming for therapy","volume":"163","author":"Bart","year":"2021","journal-title":"Immunology"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827823051498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827823051498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:49:47Z","timestamp":1759175387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827823051498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0168827823051498"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2023.09.022","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Macrophages make a difference in cholestatic liver diseases \u2013 but how?","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2023.09.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2023.08.016","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}